Antonucci T K, Rutter W J
Hormone Research Institute, University of California, San Francisco 94143.
J Virol. 1989 Feb;63(2):579-83. doi: 10.1128/JVI.63.2.579-583.1989.
The activities of the individual hepatitis B virus (HBV) promoters and the effects of the HBV enhancer on these promoters in several human cell types have been compared by measuring the activity and RNA levels of the linked reporter function chloramphenicol acetyltransferase. The relative promoter activities in the human HepG2 (liver), HeLa, and HS27 (fibroblast) cell lines are in the order precore greater than X greater than preS2 greater than preS1; thus, the promoters of the gene producing the largest quantity of viral proteins have relatively low activity. The juxtaposition of the HBV enhancer in either orientation increased the promoter activities only modestly (2- to 5-fold) in the nonliver cell lines, whereas it dramatically increased (20- to 100-fold) the promoter activities in the liver cell line. Thus, the HBV enhancer is especially active in liver cells. This may be one of the causes of hepatotrophicity of the virus.
通过测量与报告基因氯霉素乙酰转移酶相连的活性和RNA水平,比较了几种人类细胞类型中单个乙型肝炎病毒(HBV)启动子的活性以及HBV增强子对这些启动子的影响。在人肝癌细胞系HepG2(肝脏)、HeLa细胞系和HS27(成纤维细胞)细胞系中,相对启动子活性的顺序为前核心区大于X区大于前S2区大于前S1区;因此,产生大量病毒蛋白的基因的启动子活性相对较低。无论HBV增强子以何种方向并列,在非肝细胞系中仅适度增加启动子活性(2至5倍),而在肝细胞系中显著增加(20至100倍)启动子活性。因此,HBV增强子在肝细胞中特别活跃。这可能是该病毒嗜肝性的原因之一。